These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 19054164)

  • 1. Late-onset hypogonadism (LOH) and androgens: validity of the measurement of free testosterone levels in the diagnostic criteria in Japan.
    Iwamoto T; Yanase T; Horie H; Namiki M; Okuyama A
    Int J Urol; 2009 Feb; 16(2):168-74. PubMed ID: 19054164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Late-onset hypogonadism in the aging male (LOH): definition, diagnostic and clinical aspects.
    Schubert M; Jockenhövel F
    J Endocrinol Invest; 2005; 28(3 Suppl):23-7. PubMed ID: 16042356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The efficacy of testosterone ointment (Glowmin) treatment for late-onset-hypogonadism (LOH) patients according to LOH severity].
    Amano T; Imao T; Takemae K; Iwamoto T; Baba K; Yamakawa K; Nakazawa R; Yoshida K; Sugimori H; Tanaka T; Katabami T; Tanaka M
    Hinyokika Kiyo; 2007 Jan; 53(1):25-9; discussion 29. PubMed ID: 17310765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on evaluation methods for serum testosterone level for PADAM diagnosis.
    Tsujimura A; Matsumiya K; Miyagawa Y; Takao T; Fujita K; Takada S; Koga M; Iwasa A; Takeyama M; Okuyama A
    Int J Impot Res; 2005; 17(3):259-63. PubMed ID: 15616608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: scientific background and rationale.
    Lunenfeld B; Saad F; Hoesl CE
    Aging Male; 2005 Jun; 8(2):59-74. PubMed ID: 16096160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Bone and Men's Health. Late-onset hypogonadism in males and male menopause (andropause)].
    Komiya A; Watanabe A; Fuse H
    Clin Calcium; 2010 Feb; 20(2):234-44. PubMed ID: 20118516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of relationships between plasma androgens level and clinical signs of hipoandrogenism according to age and comorbidity of metabolic syndrome in men].
    Herman WA; Krzoska A; Pawliczak E; Roszak M; Łacka K
    Pol Merkur Lekarski; 2014 Jan; 36(211):16-21. PubMed ID: 24645572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary testosterone: a reliable approach to the diagnosis of male hypogonadism.
    Arregger AL; Contreras LN; Tumilasci OR; Aquilano DR; Cardoso EM
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):656-62. PubMed ID: 17953627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Symptomatic evaluation of late onset hypogonadism in healthy Chinese men].
    Li JY; Li XY; Li M; Zhang GK; Ma FL; Liu ZM; Zhang NY; Meng P
    Zhonghua Nan Ke Xue; 2007 Apr; 13(4):320-3. PubMed ID: 17491264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of hypogonadism in the aging male.
    Vermeulen A; Kaufman JM
    Aging Male; 2002 Sep; 5(3):170-6. PubMed ID: 12471777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of androgen in the elderly. Clinical androgen replacement therapy for late-onset hypogonadism].
    Amano T
    Clin Calcium; 2013 Aug; 23(8):1179-84. PubMed ID: 23892219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relevant clinical and biological criteria for the diagnosis of androgen deficiency in the aging male (ADAM)].
    Seisen T; Rouprêt M; Gallais JL; Costa P
    Prog Urol; 2012 Jun; 22 Suppl 1():S21-6. PubMed ID: 22770497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of salivary testosterone and dehydroepiandrosterone using LC-MS/MS: Method development and evaluation of applicability for diagnosis and medication for late-onset hypogonadism.
    Shibayama Y; Higashi T; Shimada K; Odani A; Mizokami A; Konaka H; Koh E; Namiki M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2615-23. PubMed ID: 19010090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset male hypogonadism: clinical and laboratory evaluation.
    Ho CK; Beckett GJ
    J Clin Pathol; 2011 Jun; 64(6):459-65. PubMed ID: 21486896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Change in testosterone concentrations over time is a better predictor than the actual concentrations for symptoms of late onset hypogonadism.
    Holm AC; Fredrikson MG; Theodorsson E; Palmefors LG; Karlsson PS; Joborn C; Hammar ML
    Aging Male; 2011 Dec; 14(4):249-56. PubMed ID: 21627562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum and salivary testosterone levels in erectile dysfunction].
    Corradi G; Szathmári M
    Orv Hetil; 1998 Aug; 139(34):2021-4. PubMed ID: 9745307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic criteria for late-onset hypogonadism: A preliminary study].
    DU JP; Li FP; Zheng XB; Lan BY; Lin DZ; Li Y; Yan L
    Zhonghua Nan Ke Xue; 2016 Nov; 22(11):979-983. PubMed ID: 29281204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of assay quality and reference ranges on clinical decision making in the diagnosis of androgen disorders.
    Bhasin S; Zhang A; Coviello A; Jasuja R; Ulloor J; Singh R; Vesper H; Vasan RS
    Steroids; 2008 Dec; 73(13):1311-7. PubMed ID: 18687348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Androgen Deficiency of Aging Men (ADAM) questionnaire useful for the screening of partial androgenic deficiency of aging men?
    Blümel JE; Chedraui P; Gili SA; Navarro A; Valenzuela K; Vallejo S
    Maturitas; 2009 Aug; 63(4):365-8. PubMed ID: 19481382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.